Focused Wealth Management, Inc Axsome Therapeutics, Inc. Transaction History

Focused Wealth Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 21, 2020	SELL	$16.71 - $106.24 $17,545 - $111,552	-1,050 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$20.24 - $29.16 $21,252 - $30,618	1,050 New	1,050 $21,000
Q2 2019 Jul 19, 2019	SELL	$13.46 - $25.75 $60,570 - $115,875	-4,500 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$2.63 - $16.34 $11,835 - $73,530	4,500 New	4,500 $64,000

327

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.